CEA and CA19-9 Levels and KRAS Mutation Status as Biomarkers for Colorectal Cancer. Subki, A., H., Alghamdi, T., A., Butt, N., S., Alqazlan, M., S., Alkahtani, A., M., Aziz, M., A., & others Clin Oncol, 6:1802, 2021.
bibtex   
@article{
 title = {CEA and CA19-9 Levels and KRAS Mutation Status as Biomarkers for Colorectal Cancer},
 type = {article},
 year = {2021},
 pages = {1802},
 volume = {6},
 id = {fa7589b4-d14f-330b-afb6-9cbc2d9cd23e},
 created = {2021-08-31T15:29:45.255Z},
 file_attached = {false},
 profile_id = {49efd9d1-b84a-3562-b8db-36e64ac7ba81},
 last_modified = {2022-02-11T11:41:45.902Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {true},
 hidden = {false},
 citation_key = {subki2021cea},
 source_type = {article},
 folder_uuids = {6fdaeed4-e99e-439a-bbea-44c55d8166f2},
 private_publication = {false},
 bibtype = {article},
 author = {Subki, A H and Alghamdi, T A and Butt, N S and Alqazlan, M S and Alkahtani, A M and Aziz, M A and others, undefined},
 journal = {Clin Oncol}
}

Downloads: 0